Table 3. Changes in the heart rate from baseline.
Placebo | Low-dose carvedilol ER | High-dose carvedilol ER | p value# | |
Week 2 | 0.7 ± 7.6 | -3.6 ± 8.3 | -1.9 ± 10.8 | 0.092 |
p = 0.565 | p = 0.007 | p = 0.240 | ||
Week 4 | 0.5 ± 8.3 | -4.0 ± 7.5 | -6.5 ± 11.1 | 0.002 |
p = 0.680 | p = 0.001 | p < 0.001 | ||
Week 8 | -1.2 ± 9.9 | -8.4 ± 9.0 | -8.6 ± 11.0 | < 0.001 |
p = 0.449 | p < 0.001 | p < 0.001 |
* Data were based on the safety population. # Between-group differences were compared by the analysis of variance model.
ER, extended-release.